Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
0.6649
+0.0503 (8.18%)
At close: Apr 1, 2026, 4:00 PM EDT
0.6250
-0.0399 (-6.00%)
Pre-market: Apr 2, 2026, 4:13 AM EDT
Skye Bioscience Employees
Skye Bioscience had 12 employees as of December 31, 2025. The number of employees decreased by 4 or -25.00% compared to the previous year.
Employees
12
Change (1Y)
-4
Growth (1Y)
-25.00%
Revenue / Employee
n/a
Profits / Employee
-$4,660,401
Market Cap
22.19M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 12 | -4 | -25.00% |
| Dec 31, 2024 | 16 | 5 | 45.45% |
| Dec 31, 2023 | 11 | 0 | - |
| Dec 31, 2022 | 11 | 2 | 22.22% |
| Dec 31, 2021 | 9 | 3 | 50.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Senti Biosciences | 34 |
| Curis | 34 |
| Passage Bio | 24 |
| Tempest Therapeutics | 21 |
| Outlook Therapeutics | 17 |
| VYNE Therapeutics | 10 |
| Neuphoria Therapeutics | 8 |
| Lexaria Bioscience | 7 |
SKYE News
- 22 days ago - Skye Bioscience Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 27 days ago - Skye Bioscience to Announce 2025 Financial Results and Business Update on March 10, 2026 - GlobeNewsWire
- 2 months ago - Penny Stock Skye Bioscience Drug Combo With Wegovy Shows Over 22% Weight Loss After One Year - Benzinga
- 2 months ago - Skye Reports Positive CBeyond Phase 2a Extension Interim Study Results for Nimacimab in Combination With Semaglutide - GlobeNewsWire
- 2 months ago - Skye Bioscience Highlights Attributes of its Peripherally-restricted CB1 Inhibitor Antibody at Keystone Obesity Conference - GlobeNewsWire
- 2 months ago - Skye Bioscience to Present Poster at Keystone Obesity Conference - GlobeNewsWire
- 2 months ago - INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience - Newsfile Corp
- 2 months ago - INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience - GlobeNewsWire